Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03068377 · ClinicalTrials.gov registry record · NA
The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow
A NA study of Ocular Blood Flow, sponsored by LycoRed.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03068377 is a NA study of Ocular Blood Flow that has completed, run by LycoRed. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03068377, a NA study of Ocular Blood Flow, has completed, sponsored by LycoRed.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives:To determine LYC-001e's influences on ocular blood flow Ocular blood flow has been implicated as a parameter relevant to eye health and involved in the disease process of several ophthalmic pathologies including AMD, glaucoma, and diabetes We hypothesis that LYC-001e will increase measures of ocular blood flow in healthy individuals Methods: This is a single-phase, randomized, parallel, double blind , comparative study of LYC-001e versus placebo on ocular blood vessels in healthy individuals.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Experimental
Study Locations (1)
Indiana
- Glaucoma Research and Diagnostic Center Eugene and Marilyn Glick Eye Institute Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2018-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03068377
The ClinicalTrials.gov registry entry for NCT03068377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LycoRed, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ocular Blood Flow appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03068377 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03068377 about?
NCT03068377 is a clinical study titled "The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow". Objectives:To determine LYC-001e's influences on ocular blood flow Ocular blood flow has been implicated as a parameter relevant to eye health and involved in the disease process of several ophthalmic pathologies including AMD, glaucoma, and diabetes We hypothesis that LYC-001e will increase measure...
What is the current status of trial NCT03068377?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-03-20. Estimated completion is 2018-12-30.
What conditions does trial NCT03068377 study?
This clinical trial studies the following conditions: Ocular Blood Flow.
What interventions are being tested in trial NCT03068377?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Experimental (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03068377?
This trial is sponsored by LycoRed, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03068377 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.